Abstract
This study shows that there is cross resistance of tubercle bacilli to Niamid® and Isoniazid. When Niamid is administered to a patient, thorough studies should be carried out to determine if the patient also has active tuberculosis. If so, a second anti-tuberculous drug should also be used, in accordance with currently established principles of combined drug therapy for tuberculosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
